SelectScience InterviewsLife Sciences
Targeting tumor mutations with personalized T cell therapy of cancer
18 May 2021
Watch this presentation by Dr. Gavin Bendle, Vice President of R&D at Neogene Therapeutics, titled: Targeting tumor mutations with personalized T cell therapy of cancer. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
